BioVersys reports results from Phase 2a ENABLE study for tuberculosis treatments containing AlpE
The results from the Phase 2a ENABLE trial provide important clinical evidence supporting the continued development of AlpE as a…
BEAM at work
Our advocacy work is based on analysis and reflection with our members.
Each topic is dealt with by a task force, which acts as a discussion platform and issues policy briefs.